Ongoing increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: A 50-year study

Author:

Ribbons Karen1,Lea Rodney2,Tiedeman Clare3,Mackenzie Laura4,Lechner-Scott Jeannette5

Affiliation:

1. Department of Neurology, John Hunter Hospital, New Lambton, NSW, Australia

2. Hunter Medical Research Institute, Newcastle, NSW, Australia

3. Department of Medicine, John Hunter Hospital, New Lambton, NSW, Australia

4. School of Health Sciences, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia

5. Department of Neurology, John Hunter Hospital, New Lambton, NSW, Australia/Hunter Medical Research Institute, Newcastle, NSW, Australia/School of Health Sciences, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia

Abstract

Background: Since 1959, multiple sclerosis (MS) prevalence has been estimated for the east coast Australian city of Newcastle. Previous surveys, conducted in 1988 and 2003, have described an increase in the prevalence and incidence of MS. Objectives: In this study, we evaluated whether these trends continue and provide 50 years of MS epidemiological follow-up for this southern hemisphere city. Methods: Expressed per 100,000 people, prevalence of MS in Newcastle was calculated for those with a confirmed diagnosis of MS on 9 August 2011 and incidence based on the number of cases with MS diagnosis made during the preceding decade. Data were age-standardised to the total Australian population. Statistical comparisons were undertaken using Poisson regression analysis. Results: In 2011, the estimate of MS prevalence was 124.2, with female-to-male ratio reaching 3.1, a 53% increase in female predominance since 1996. MS incidence increased to 6.7, with a significantly higher proportion of new female cases since the previous survey. Conclusion: Prevalence of MS in Newcastle has risen linearly and is contributed to by a substantial increase in new cases over the preceding decade. Female predominance of MS cases continues to increase with a new diagnosis three times more likely in women.

Funder

Teva Pharmaceutical Industries

bioCSL

Publisher

SAGE Publications

Subject

Neurology (clinical),Neurology

Cited by 50 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Longitudinal epidemiology of multiple sclerosis over 60 years in Newcastle, Australia: 1961 to 2021;Multiple Sclerosis and Related Disorders;2024-10

2. Prevalence and Burden of Multiple Sclerosis in China, 1990–2019;Neurology;2024-06-11

3. Where does multiple sclerosis come from?;Multiple Sclerosis and Related Disorders;2024-05

4. NMDA Receptor Antagonist Memantine Ameliorates Experimental Autoimmune Encephalomyelitis in Aged Rats;Biomedicines;2024-03-23

5. Diet and neuroplasticity;Reference Module in Neuroscience and Biobehavioral Psychology;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3